ArticleJournal of neurology2011
Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings.
Article in Journal of neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.
- Acquired paroxysmal dysarthria-ataxia syndrome: A systematic review of clinical and MRI findings.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Pooled it
- Vestibular paroxysmia: a systematic review.Journal of neurology · 2025Pooled it
- A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis.Neurology and therapy · 2022Review
- Movement Disorders in Multiple Sclerosis: An Update.Tremor and other hyperkinetic movements (New York, N.Y.) · 2022Review
- Demyelination and remyelination detected in an alternative cuprizone mouse model of multiple sclerosis with 7.0 T multiparameter magnetic resonance imaging.Scientific reports · 2021Article
- Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach inFrontiers in neurology · 2021Article
- Paroxysmal Symptoms in Multiple Sclerosis-A Review of the Literature.Journal of clinical medicine · 2020Review
- Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.International journal of molecular sciences · 2020Review
- Solitary sclerosis presenting as isolated spontaneous paroxysmal dysarthria.eNeurologicalSci · 2019Article
- Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia.Current treatment options in neurology · 2016Review
- Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome.Journal of neurology · 2016Review
- Vestibular paroxysmia: Diagnostic criteria.Journal of vestibular research : equilibrium & orientation · 2016Article
- Clinically isolated syndrome presenting as paroxysmal dysarthria: a rare but typical presentation.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2014Article
- Isolated paroxysmal dysarthria caused by a single demyelinating midbrain lesion.BMJ case reports · 2013Article
- Diagnosis and misdiagnosis of cerebrovascular disease.Current treatment options in cardiovascular medicine · 2013Article
- Harry Lee Parker and paroxysmal dysarthria and ataxia.Neurology · 2013Article
- Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis.Iranian journal of neurology · 2012Article
- Lamotrigine therapy for paroxysmal dysarthria caused by multiple sclerosis: a case report.Journal of neurology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paroxysmal dysarthria (PD) and paroxysmal dysarthria-ataxia (PDA) syndromes are uncommon symptoms of the neurological dysfunction in multiple sclerosis (MS). We describe two patients who had clinically definite MS presented with symptomatic PD and PDA syndromes, respectively, related to demyelinating lesions. In one patient, the PD symptom was the initial manifestation of an acute episode. In the other patient, the episode of dysarthria was accompanied by ataxia disorders. Both patients had midbrain lesions at or below the level of the right red nucleus on magnetic resonance imaging (MRI), confirming that this area is critically involved. Both responded well to carbamazepine (CBZ).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.